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Background: The aim of the study was to determine the safety and efficacy of a novel thermal femoral artery closure device (CardioDex; Caesarea, 
Israel). The device is comprised of a Nitinol anchor that is deployed via the existing introducer sheath, a battery power unit and a heating member 
inserted over the anchor wire and positioned on the arteriotomy site. Local heating with two 5 sec pulses achieves hemostasis by causing collagen 
cross linking and leaves no residual material at the puncture site.
Methods: First in man experience was obtained in a prospective nonrandomized single-center series. Inclusion criteria were 5F - 7F femoral 
arterial puncture and target vessel diameter > 6 mm. Exclusions were coagulation disorder, GP IIb/IIIa inhibitors or use of warfarin. Femoral 
artery closure was performed immediately at completion of the procedure, followed by 3 min of manual compression for diagnostic and 4 min for 
interventional. Time to hemostasis (TTH), time to ambulation (TTA), and short-term clinical follow-up data were collected.
Results: 84 patients were enrolled including 42 diagnostic cardiac caths and 42 PCI. The mean age was 64 yrs, 83 % were on ASA 100 - 150 mg, 
23 % on clopidogrel 75 mg, 19 % on dual antiplatelet therapy and 50 % received heparin 4,000 - 10,000U during the procedure.
Procedural success was 100 % and device success 100 %. The median device delivery time (from insertion through the introducer sheath until 
beginning of manual compression) was 2:23 (0:42 - 5:40 min), median TTH was 4:01 (3:00 - 13:57 min), and median TTA was 2:20 (2:00 - 4:00 
hours). Median TTH for Diagnostic vs. PCI were 3 (3, 3.25 min) and 4 (4, 4.14 min), p = NS, respectively. TTH was independent of ACT. There were 
no major adverse events including large (>4 cm) hematoma, transfusion, pseudoaneurysm or arteriovenous fistula during 1 week follow up. Arterial 
ultrasound was performed in 30 patients at 30 days and was negative in all.
Conclusion: Initial clinical experience suggests that femoral artery closure with the Cardiodex thermal closure device following diagnostic 
catheterization and PCI is safe and effective. This unique biological system has the particular advantage of sealing with no residual materials left 
behind.
